Brooks Laboratories Limited (NSE:BROOKS)
68.55
+3.26 (4.99%)
Jun 1, 2026, 3:24 PM IST
Brooks Laboratories Revenue
In the fiscal year ending March 31, 2026, Brooks Laboratories had annual revenue of 869.09M INR with 5.27% growth. Brooks Laboratories had revenue of 206.48M in the quarter ending March 31, 2026, a decrease of -11.45%.
Revenue
869.09M
Revenue Growth
+5.27%
P/S Ratio
2.32
Revenue / Employee
2.69M
Employees
323
Market Cap
2.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 869.09M | 43.52M | 5.27% |
| Mar 31, 2025 | 825.57M | 30.71M | 3.86% |
| Mar 31, 2024 | 794.86M | 162.81M | 25.76% |
| Mar 31, 2023 | 632.05M | -279.80M | -30.69% |
| Mar 31, 2022 | 911.85M | 139.38M | 18.04% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sigachi Industries | 4.86B |
| Jagsonpal Pharmaceuticals | 2.87B |
| Balaxi Pharmaceuticals | 2.73B |
| Valiant Laboratories | 2.37B |
| Bafna Pharmaceuticals | 1.55B |
| Alpa Laboratories | 1.22B |
| Vaishali Pharma | 1.14B |
| Par Drugs and Chemicals | 1.08B |